Safety and immunologic effects of high- vs low-dose cholecalciferol in multiple sclerosis.
about
Vitamin D in Autoimmunity: Molecular Mechanisms and Therapeutic Potential.1,25 (OH)2D3 treatment alters the granulomatous response in M. tuberculosis infected miceNarrowband UVB Phototherapy for Clinically Isolated Syndrome: A Trial to Deliver the Benefits of Vitamin D and Other UVB-Induced Molecules.Zika Virus as an Emerging Neuropathogen: Mechanisms of Neurovirulence and Neuro-Immune Interactions.Vitamin D supplementation in the prevention and management of major chronic diseases not related to mineral homeostasis in adults: research for evidence and a scientific statement from the European society for clinical and economic aspects of osteopVitamin D: not just the bone. Evidence for beneficial pleiotropic extraskeletal effects.Metabolites: deciphering the molecular language between DCs and their environment.Exploring the effect of vitamin D3 supplementation on the anti-EBV antibody response in relapsing-remitting multiple sclerosis.Metabolomics analysis of serum 25-hydroxy-vitamin D in the Alpha-Tocopherol, Beta-Carotene Cancer Prevention (ATBC) Study.Effects of vitamin D3 in clinically isolated syndrome and healthy control participants: A double-blind randomised controlled trial.Vitamin D in the prevention, prediction and treatment of neurodegenerative and neuroinflammatory diseases.Vitamin D and Multiple Sclerosis: A Comprehensive Review.Wellness and the Role of Comorbidities in Multiple Sclerosis.T-lymphocyte and glycemic status after vitamin D treatment in type 1 diabetes: A randomized controlled trial with sequential crossover.Genomic Effects of the Vitamin D Receptor: Potentially the Link between Vitamin D, Immune Cells, and Multiple Sclerosis.Vitamin D3 Supplementation Reduces Subsequent Brain Injury and Inflammation Associated with Ischemic Stroke.The Engagement Between Vitamin D and the Immune System: Is Consolidation by a Marriage to Be Expected?
P2860
Q34550631-F5DB0186-29EA-4BA1-9645-BDFF9FBEF54AQ37307021-22354745-579C-40A6-988E-29B60ED95839Q37599437-78A44DE6-405B-4A2E-9FD0-16FFAAB6FB89Q38158918-97E26FC0-7368-46BC-9A40-B93468EA8597Q38733247-B27DF7C0-310A-44BA-81A5-D6C68998E439Q38934985-EB3D1AB1-550D-4B3F-824A-B16F8DAC5144Q39030292-727960F5-6950-4D15-A50A-23CCCA7B3996Q40113533-68B26B87-7DA6-4C90-A07D-2766D5DB9F58Q40622136-F6C3D0F9-0099-4CAC-AE86-E5348F35252BQ42364107-429E2995-4CBC-436D-A153-62434C23B925Q47163794-4115A1E4-AC62-4012-977A-77C5567A61CCQ47306228-FCEA5828-5FF5-42AC-AA40-F66E9D43694BQ48162662-DB3C2CB6-C875-4F5A-8416-0BA97BE8961DQ50567211-38414195-91C2-47AE-A8C1-68954235C605Q51415619-615A36F4-62F3-445E-A87A-D8E01CBC9E44Q52687545-621BE985-642F-4F97-9473-9FE8A5104CFDQ55311856-17D03359-A355-4B69-9DC4-9AC285A43BEB
P2860
Safety and immunologic effects of high- vs low-dose cholecalciferol in multiple sclerosis.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Safety and immunologic effects ...... ciferol in multiple sclerosis.
@ast
Safety and immunologic effects ...... ciferol in multiple sclerosis.
@en
type
label
Safety and immunologic effects ...... ciferol in multiple sclerosis.
@ast
Safety and immunologic effects ...... ciferol in multiple sclerosis.
@en
prefLabel
Safety and immunologic effects ...... ciferol in multiple sclerosis.
@ast
Safety and immunologic effects ...... ciferol in multiple sclerosis.
@en
P2093
P2860
P50
P1433
P1476
Safety and immunologic effects of high- vs low-dose cholecalciferol in multiple sclerosis
@en
P2093
Achilles Ntranos
Anne Gocke
Christopher Eckstein
Lawrence Steinman
Moira Baynes
Pavan Bhargava
P2860
P304
P356
10.1212/WNL.0000000000002316
P407
P577
2015-12-30T00:00:00Z